NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Cardio Diagnostics Holdings (CDIO) Precision Cardiovascular Solutions

Cardio Diagnostics Holdings is a precision cardiovascular medicine company that uses epigenetics, genetics, and artificial intelligence to develop clinical tests for cardiovascular disease prevention, detection, and management.
The company presented innovative approaches to cardiovascular disease prevention, risk assessment, and cost management, highlighting how advanced risk assessment and detection tools can support better health outcomes and more effective healthcare cost management.
The solutions are aimed at employers and health plans, helping them identify elevated risk or silent disease early to enable targeted interventions and preventive care.
The company leverages a proprietary AI-driven Integrated Genetic-Epigenetic Engine (Core Technology) to analyze genetic and epigenetic markers for precise cardiovascular risk assessment.
Early identification enables more targeted interventions and preventive care, potentially preventing major cardiovascular events and reducing healthcare costs.
The presentations took place at multiple national benefits conferences in July 2026, as reported in a news release from Los Angeles, CA.
It aligns with trends in population health management and proactive risk reduction, potentially leading to better health outcomes and more effective cost management.
The latest news and updates are available in the company’s newsroom at https://ibn.fm/CDIO.
